Business
Aussie cannabis players blaze a trail in Europe – The Australian Financial Review
ASX-listed MGC Pharma has floated in London while Little Green Pharma has placed $22 million of shares, as the high-potential European market beckons.
Australia is so set up to have a really great crack at being the dominant player in Europe, said LGP founder and CEO Fleta Solomon.
She said the Australian advantage was that the Therapeutic Goods Associations good manufacturing practice (GMP) standards were recognised as complying with the European Unions high bar, whereas producers in other countries had to negotiate EU clearance.
The biggest companies in the world dont have EU GMP. Thats what is so exciting for us as Australian players. Our GMP…
-
Business23 hours agoThe ultimate Australian stocks to buy and hold for 10+ years
-
Noosa News19 hours agoLNP Premier David Crisafulli announces ‘Queensland’s royal commission’ into CFMEU
-
Noosa News24 hours agoNew process turns wheat straw and oat husks into sustainable clothing
-
Noosa News19 hours agoSouthern NSW farmers call for financial relief as ongoing drought takes a toll